^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    S-oxprenolol (ACM-002)

    i
    Other names: ACM-002
    Associations

    News

    Trials
    Company:
    Actimed Therap, Faraday Pharma
    Drug class:
    β1 adrenergic receptor antagonist
    Related drugs:
    Associations

    News

    Trials
    3years
    The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model. (PubMed, J Cachexia Sarcopenia Muscle)
    S-oxprenolol is superior to R-oxprenolol in cancer cachexia animal models and shows promise for a human application in cancer cachexia.
    Preclinical • Journal
    |
    IGF1 (Insulin-like growth factor 1) • AMPK (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1)
    |
    S-oxprenolol (ACM-002)